Alex Gorsky, J&J CEO (Andrew Harnik/AP Images)
J&J sets out to split the world's largest healthcare conglomerate, hiving off the consumer division
J&J is joining the movement in pharma to double down on risky but high-growth drugs and devices while hiving off huge consumer divisions. CEO Alex …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
